GET THE APP

..

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Shalini T

Priveel Peptides Ltd., Regus Business Center, RMZ Milenia Business Park, Dr. M.G.R. Road, Kadanchavady, Chennai, Tamil Nadu, India

Publications
  • Review Article   
    CRISPR/Cas9 and its Delivery Methods for Duchenne Muscular Dystrophy (DMD) Gene Therapies
    Author(s): Shalini T*

    Duchenne Muscular Dystrophy (DMD) is a X linked genetic disorder that causes difficulty in walking, followed by progressive skeletal muscle degeneration and some cardiac muscle related issues, that threatens the life expectancy of patients. This condition is due a mutation in a gene that produces cytoskeletal protein termed as dystrophin. Targeting this gene to correct or bypass the mutation would benefit in effective therapies for DMD. CRISPR/Cas9 (Clustered Regularly Interspaced Palindromic Repeats) technology has created an evolution in precise gene modification techniques. With the help of a guide RNA, Cas9 (a DNA endonuclease) can create a double strand breaks to carry out the targeted gene modifications. By simply modifying the guide RNA sequences, Cas9 can be used for flexible programming of new target sites. The prime factor that determines the therapeutic.. Read More»

    Abstract HTML PDF

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward